These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36562202)

  • 1. The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study.
    Suleiman A; Munoz-Acuna R; Azimaraghi O; Houle TT; Chen G; Rupp S; Witt AS; Azizi BA; Ahrens E; Shay D; Wongtangman K; Wachtendorf LJ; Tartler TM; Eikermann M; Schaefer MS
    Anaesthesia; 2023 Mar; 78(3):294-302. PubMed ID: 36562202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
    Kheterpal S; Vaughn MT; Dubovoy TZ; Shah NJ; Bash LD; Colquhoun DA; Shanks AM; Mathis MR; Soto RG; Bardia A; Bartels K; McCormick PJ; Schonberger RB; Saager L
    Anesthesiology; 2020 Jun; 132(6):1371-1381. PubMed ID: 32282427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study.
    Colquhoun DA; Vaughn MT; Bash LD; Janda A; Shah N; Ghaferi A; Sjoding M; Mentz G; Kheterpal S;
    Br J Anaesth; 2023 Jan; 130(1):e148-e159. PubMed ID: 35691703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative oxygenation assessed by SpO
    Schmidt M; Rössler J; Brooker J; Lara-Erazo V; Ekrami E; Pu X; Turan A; Sessler DI; Ruetzler K
    J Clin Anesth; 2023 Sep; 88():111138. PubMed ID: 37148836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.
    Bash LD; Turzhitsky V; Mark RJ; Hofer IS; Weingarten TN
    J Clin Anesth; 2024 May; 93():111344. PubMed ID: 38007845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Pulmonary Complications' Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis.
    Li G; Freundlich RE; Gupta RK; Hayhurst CJ; Le CH; Martin BJ; Shotwell MS; Wanderer JP
    Anesthesiology; 2021 Jun; 134(6):862-873. PubMed ID: 33730169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis.
    Ren A; Fan M; Gu Z; Liang X; Xu L; Liu C; Wang D; Chang H; Zhu M
    Br J Clin Pharmacol; 2024 Jul; 90(7):1667-1676. PubMed ID: 38583490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Sugammadex or Neostigmine With Major Postoperative Pulmonary Complications in Children.
    Beltran RJ; Mpody C; Nafiu OO; Tobias JD
    Anesth Analg; 2022 Nov; 135(5):1041-1047. PubMed ID: 35020682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study.
    Azimaraghi O; Ahrens E; Wongtangman K; Witt AS; Rupp S; Suleiman A; Tartler TM; Wachtendorf LJ; Fassbender P; Choice C; Houle TT; Eikermann M; Schaefer MS
    Br J Anaesth; 2023 Mar; 130(3):296-304. PubMed ID: 36535827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design.
    Krause M; McWilliams SK; Bullard KJ; Mayes LM; Jameson LC; Mikulich-Gilbertson SK; Fernandez-Bustamante A; Bartels K
    Anesth Analg; 2020 Jul; 131(1):141-151. PubMed ID: 31702700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How robust are the STRONGER and STIL-STRONGER studies?
    Blobner M; Hunter JM; Ulm K
    Br J Anaesth; 2023 Jan; 130(1):e41-e44. PubMed ID: 36182557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sugammadex and neostigmine on outcome after major orthopaedic surgery: A population-based analysis.
    Cozowicz C; Zhong H; Poeran J; Illescas A; Liu J; Poultsides LA; Athanassoglou V; Memtsoudis SG
    Eur J Anaesthesiol; 2024 May; 41(5):374-380. PubMed ID: 38497249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.